Sugargic MV 2mg/500mg/0.3mg Tablet SR
Marketer
Neorangic Healthcare Private Limited
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.3mg)
Overview Sugargic MV 2mg/500mg/0.3mg Tablet SR
Diabetic medication, Glycemia-Control 2/500/0.3mg Extended-Release Tablets, is an anti-diabetic combination therapy for adult type 2 diabetes. It manages blood glucose levels, and should be taken with meals at the same time daily as prescribed. Dosage adjustments are determined by your physician based on your blood sugar control. Continuous use, even with controlled blood sugar, is crucial. Discontinuing without medical advice risks elevated blood glucose, potentially causing kidney damage, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive treatment plan including diet, exercise, and weight management as recommended by your doctor. The most frequent adverse effect is hypoglycemia (low blood sugar). Learn to recognize symptoms like sweating, dizziness, headache, and tremors, and carry a fast-acting glucose source. Alcohol increases hypoglycemia risk and should be avoided. Other potential side effects encompass altered taste, nausea, diarrhea, abdominal pain, headache, edema, blurred vision, bone fractures, upper respiratory infections, and weight gain. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe liver or kidney disease. Inform your doctor of any heart condition history before commencing treatment. Pregnant or breastfeeding individuals should seek medical consultation before use. Regular blood glucose monitoring and periodic blood tests (blood cell counts and liver function) are recommended by your physician.
Uses of Sugargic MV 2mg/500mg/0.3mg Tablet SR
Managing Type 2 Diabetes
Major Benefits of Sugargic MV 2mg/500mg/0.3mg Tablet SR:
Follow your physician's instructions precisely regarding dosage and treatment length for this medication. Ingest the Sugargic MV 2mg/500mg/0.3mg Tablet SR whole; avoid chewing, crushing, or fracturing it. Administer on an empty stomach.
Common Side effects of Sugargic MV 2mg/500mg/0.3mg Tablet SR:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Sugargic MV 2mg/500mg/0.3mg Tablet SR:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the entire tablet without chewing, crushing, or breaking it. Sugargic MV 2mg/500mg/0.3mg Sustained-Release tablets should be consumed on an empty stomach.
How Sugargic MV 2mg/500mg/0.3mg Tablet SR works:
Extended-release Sugargic MV tablets (2mg/500mg/0.3mg) contain a triple-action antidiabetic formulation.
SAFETY ADVICE
AlcoholUNSAFE
Combining Sugargic MV 2mg/500mg/0.3mg Tablet SR with alcohol is not advisable due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
The use of Sugargic MV 2mg/500mg/0.3mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The extended-release Sugargic MV 2mg/500mg/0.3mg tablet likely poses a risk during lactation. Available human data indicates potential transfer to breast milk, possibly harming the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyUNSAFE
The use of Sugargic MV 2mg/500mg/0.3mg SR tablets is likely unsafe for individuals with kidney impairment and should be omitted. Patients should seek medical advice. Furthermore, this medication is contraindicated in patients exhibiting severe kidney dysfunction.
LiverCAUTION
Patients with liver impairment should use Sugargic MV 2mg/500mg/0.3mg SR tablets cautiously, potentially requiring dose modification. Consult a physician. A reduced initial dosage is typically advised for those with mild to moderate liver disease; the medication is contraindicated in cases of severe hepatic dysfunction.
What if you forget to take Sugargic MV 2mg/500mg/0.3mg Tablet SR :
Should you forget to take your Sugargic MV 2mg/500mg/0.3mg Tablet SR, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing pattern. Avoid taking a double dose.
Facts to Know About Sugargic MV 2mg/500mg/0.3mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Medication |
3,018 People bought this recently